These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7502820)

  • 1. Interaction of natural and synthetic peptides derived from gliadin with different cell lines.
    Farré MA; Tlaskalová H; Nguyen HH; Kocna P; Tucková L; Krchnák V; Vetvicka V; Baudisová M; Pospisil M; Fric P
    Adv Exp Med Biol; 1995; 371B():1371-3. PubMed ID: 7502820
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
    Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
    Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of gliadin with effector and target cells in NK cell activity of patients with celiac disease.
    Nguyen HH; Farré MA; Tlaskalová H; Pospisil M; Fric P
    Adv Exp Med Biol; 1995; 371B():1359-62. PubMed ID: 7502817
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune reactions induced by gliadin.
    Tlaskalová-Hogenová H; Stepánkova R; Tucková L; Farre MA; Vetvicka V; Trávnicek J; Kolínská J; Kocna P; Fric P; Holub M
    Adv Exp Med Biol; 1995; 371B():1191-8. PubMed ID: 7502782
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells.
    De Vincenzi M; Stammati A; Luchetti R; Silano M; Gasbarrini G; Silano V
    Toxicology; 1998 May; 127(1-3):97-106. PubMed ID: 9699797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term cultivation of duodenal biopsies in patients with coeliac disease. Effect of gluten challenge and gliadin peptides.
    Kocna P; Fric P; Tlaskalová H; Krchnák V; Kasafírek E; Síová M; Czerkinsky C
    Adv Exp Med Biol; 1995; 371B():1367-70. PubMed ID: 7502819
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro activation of adenylate cyclase of atrophic celiac intestinal mucosa by wheat gliadin-derived peptides.
    Beguinot L; Auricchio S; Bernardin JE; de Ritis G; De Vincenzi M; Kasarda DD; Macchia V; Silano V
    Pediatr Res; 1986 Jan; 20(1):42-4. PubMed ID: 3945514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agglutinating activity of gliadin-derived peptides from bread wheat: implications for coeliac disease pathogenesis.
    Auricchio S; De Ritis G; De Vincenzi M; Mancini E; Minetti M; Sapora O; Silano V
    Biochem Biophys Res Commun; 1984 Jun; 121(2):428-33. PubMed ID: 6547342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural conformation and self-assembly process of p31-43 gliadin peptide in aqueous solution. Implications for celiac disease.
    Herrera MG; Gómez Castro MF; Prieto E; Barrera E; Dodero VI; Pantano S; Chirdo F
    FEBS J; 2020 May; 287(10):2134-2149. PubMed ID: 31659864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune reactions induced by gliadin feeding in germ-free AVN rats and athymic nude mice. Animal models for celiac disease.
    Tlaskalová-Hogenová H; Stĕpánková R; Farré M; Funda DP; Reháková Z; Sinkora J; Tucková L; Horak I; Horáková D; Cukrowska B; Kozáková H; Kolínská J
    Ann N Y Acad Sci; 1997 Apr; 815():503-5. PubMed ID: 9186710
    [No Abstract]   [Full Text] [Related]  

  • 11. Coeliac disease. Pathogenesis and clinical aspects.
    Friis SU
    APMIS Suppl; 1996; 61():1-48. PubMed ID: 8765057
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment.
    Vilasi S; Sirangelo I; Irace G; Caputo I; Barone MV; Esposito C; Ragone R
    J Mol Recognit; 2010; 23(3):322-8. PubMed ID: 19771572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mechanisms of gliadin immunotoxicity?
    Arranz E; Garrote JA
    Gut; 2010 Mar; 59(3):286-7. PubMed ID: 20207631
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies against deamidated gliadin peptides in early-stage celiac disease.
    Kurppa K; Lindfors K; Collin P; Saavalainen P; Partanen J; Haimila K; Huhtala H; Laurila K; Mäki M; Kaukinen K
    J Clin Gastroenterol; 2011 Sep; 45(8):673-8. PubMed ID: 21063208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct gliadin cytotoxicity as a cofactor in the pathogenesis of celiac disease.
    Elli L; Dolfini E; Bardella MT
    Int Arch Allergy Immunol; 2004 May; 134(1):88. PubMed ID: 15133305
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current concepts in the pathogenesis of celiac disease].
    Auricchio S
    Wien Klin Wochenschr; 1986 Aug; 98(16):517-20. PubMed ID: 3765639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in jejunal mucosa after long-term feeding of germfree rats with gluten.
    Stĕpánková R; Tlaskalová-Hogenová H; Sinkora J; Jodl J; Fric P
    Scand J Gastroenterol; 1996 Jun; 31(6):551-7. PubMed ID: 8789893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is gliadin harmful from the first morsel?
    Dieterich W; Schuppan D
    Dig Liver Dis; 2007 Oct; 39(10):917-21. PubMed ID: 17720638
    [No Abstract]   [Full Text] [Related]  

  • 19. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
    Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro presentation of gliadin-derived peptides by different cell lines.
    Chirdo FG; Zwirner NW; Rumbo M; Fossati CA
    Clin Chim Acta; 2002 Mar; 317(1-2):151-8. PubMed ID: 11814470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.